CGB 0.00% 2.1¢ cann global limited

QBL EGM, page-11

  1. 3,013 Posts.
    lightbulb Created with Sketch. 1919
    Good afternoon guys,

    I must address a post that has been placed in here that has misinformation about the capability of the Directors of QBL. The majority of the new deals, that have been secured for QBL/MCL, have been driven by Pnina and Sholom Feldman with the support and technical industry advice of Andrew Kavasilas and the rest of the management team.

    Deals that have been negotiated by the Directors, Pnina and Sholom Feldman

    1. MCL  - The Feldmans
    2. Medcan - The Feldmans
    3. BHC - The Feldmans
    4. HHC - The Feldmans
    5. Dedi Meiri - The Feldmans
    6. CannTab - The Feldmans
    7. Algae.Tec - The Feldmans
    8. John Easterling - The Feldmans

    BRINGING THE DEALS TOGETHER
    The Executive Chairperson Pnina Feldman and the Managing Director, Sholom Feldman, have been bringing together all the corporate pieces and companies to secure two fully vertically integrated businesses in both nutritional and medical cannabis for QBL, which is unrivalled in Australia.

    The Feldmans are passionate believers in the ability of cannabis to help so many countless people. Secondly, they are very large shareholders in the company and want to see massive shareholder wealth being created, not lost. Thirdly, they saw the incredible opportunity that this new industry could provide to QBL and due to their experience and knowledge of the ASX Rules and Requirements, navigated the very complex ASX laws and requirements to achieve this for QBL, a mining exploration company, which no other exploration company on the ASX was able to do.

    BUSINESS NETWORK
    With their extensive network through Israel and America, they have partnered with the best in the world, and they have brought on to the management team highly motivated and skilled people who they have confidence will make QBL a true world leader in this industry. It is very easy for people to commentate on Social media when they don't know the whole picture. Sholom invites any shareholder or interested party to contact him directly if they have advice on how the business can be improved because that is also the clear objective of the current board.  The deals that you see announced on the ASX have been achieved by the current board in a very short space of time, and management feels that noise and criticism has been unfairly aimed at the Board without context of the bigger picture and of their achievements over the past year.  

    DIRECTORS AND MANAGEMENT REMUNERATION
    With regards to the pay of the current management, we have noted many times on this forum, that the pay of the current management is, in fact, lower than the average in this industry for ASX cannabis companies, and in some cases, disproportionately lower. The current board and management has delivered in spades over the past year for QBL shareholders, and no one has a stronger interest for the share price to rise, and for value to be protected, than the current executive team, being also such large shareholders themselves in the company.   

    To QBL shareholders and new Investors, please be careful about what you read on Social media as it appears that many do not understand the role of the Feldman's and that of Andrew Kavasilas. This can and has led to potential misinformation or misreading of the Announcements. If you need confirmation of any information regarding QBL and its deals, the Board of QBL suggests that you contact the company directly via email or directly on the company's website.

    SUMMARY
    The Feldmans have been and are directly responsible for all the main corporate deals i.e. driving, initiating and signing of the Agreements while Andrew Kavasilas has and continues to provide Technical Advice and support.


    Thanks,

    Neil1959
    HC QBL rep
    QUEENSLAND BAUXITE LIMITED
 
watchlist Created with Sketch. Add CGB (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.